Intermittent Iv homoharringtonine for the treatment of refractory epithelial carcinoma of the ovary: a phase II trial.
D000368:Aged; D000470:Alkaloids / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D002945:Cisplatin / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006248:Harringtonines / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D000077863:Homoharringtonine; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000470:Alkaloids; D006248:Harringtonines; D000077863:Homoharringtonine; D002945:Cisplatin